USPTO serial 99890985
TRUE3D
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHOI, REBECCA EJ
- Law office
- TMO LAW OFFICE 118
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: January 30, 2027
Need help with TRUE3D?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Office Action issues
The examiner has identified that your trademark faces a refusal due to potential confusion with an existing registration and because it is considered merely descriptive of your goods and services.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aaron D. Hendelman
Aaron D. Hendelman Wilson Sonsini Goodrich & Rosati650 Page Mill RoadPalo Alto, CA 94304-1050United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents for scientific and research use, namely, multi-omic reagents for research, scientific, and clinical laboratory use; Biomarker reagents for research, scientific, and clinical laboratory use | ACTIVE | — |
| 005 | Clinical medical reagents, namely, multi-omic reagents for medical use; Diagnostic biomarker reagents for clinical medical purposes | ACTIVE | — |
| 009 | Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of biomolecules and spatial interactions between biomolecules and cells in situ; Medical laboratory research instruments for in situ multi-omic analysis, spatial transcriptomics, and protein analysis | ACTIVE | — |
| 010 | Medical instruments, namely, instruments for in situ multi-omic analysis, for diagnostic purposes | ACTIVE | — |
| 042 | Scientific research and analysis, namely, in situ multi-omic research and analysis, spatial transcriptomics research and analysis, and protein research and analysis; Clinical research in the fields of in situ multi-omic analysis, spatial transcriptomics, and protein analysis; Analysis, evaluation, and development of therapeutics medicines for research, scientific, and clinical use | ACTIVE | — |
| 044 | Medical diagnostic testing and reporting services in the fields of in situ multi-omic analysis, spatial transcriptomics, and protein analysis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Cited under §2(d): 88675362
- Other trademarks owned by Stellaromics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TRUE3D
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 30, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 17, 2026 | NWAP | NEW APPLICATION ENTERED | — |